Market Research Report
North America Alopecia (Hair Loss) Treatment Market Forecast 2021-2028
|North America Alopecia (Hair Loss) Treatment Market Forecast 2021-2028|
Published: July 19, 2021
Content info: 122 Pages
Delivery time: 2-3 business days
The North America alopecia (hair loss) treatment market is evaluated to record a CAGR of 4.40% over the forecasting period of 2021 to 2028. Key factors such as the growing emphasis on aesthetics, the well-established presence of pharmaceutical firms working towards the effective treatment of alopecia, the rising disposable income, and the increased consumption of alcohol predominantly fuel the regional market's growth.
The North America alopecia (hair loss) treatment market growth assessment entails the evaluation of Canada and the United States. Canada houses multiple non-profit organizations as well as hair specialist salons endeavoring towards treating alopecia. In this regard, Canada's charitable organization named, Canadian Alopecia Areata Foundation (CANAAF) is mainly dedicated to the condition's treatment. It predominantly extends support to individuals diagnosed with alopecia areata in Canada. The organization also promotes education and awareness regarding such autoimmune diseases and raises substantial funds for research, as well.
Conversely, Canada has a non-profit organization committed to educating, advocating, and supporting citizens living with alopecia conditions, skin diseases, and traumas. The country also witnesses a considerable rise in smoking and alcohol consumption, resulting in increased hair loss complications among Canadian adults. As a result, these factors play an essential role in facilitating the North America alopecia (hair loss) treatment market growth over the estimated years.
Some of the major companies operating in the market are: Johnson & Johnson Inc, Concert Pharmaceuticals, Merk & Co Inc, etc.